Alvarez-Mon, M.A.; Ortega, M.A.; GarcÃa-Montero, C.; Fraile-Martinez, O.; Monserrat, J.; Lahera, G.; Mora, F.; Rodriguez-Quiroga, A.; Fernandez-Rojo, S.; Quintero, J.;
et al. Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals 2021, 14, 821.
https://doi.org/10.3390/ph14080821
AMA Style
Alvarez-Mon MA, Ortega MA, GarcÃa-Montero C, Fraile-Martinez O, Monserrat J, Lahera G, Mora F, Rodriguez-Quiroga A, Fernandez-Rojo S, Quintero J,
et al. Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals. 2021; 14(8):821.
https://doi.org/10.3390/ph14080821
Chicago/Turabian Style
Alvarez-Mon, Miguel A., Miguel A. Ortega, Cielo GarcÃa-Montero, Oscar Fraile-Martinez, Jorge Monserrat, Guillermo Lahera, Fernando Mora, Alberto Rodriguez-Quiroga, Sonia Fernandez-Rojo, Javier Quintero,
and et al. 2021. "Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects" Pharmaceuticals 14, no. 8: 821.
https://doi.org/10.3390/ph14080821
APA Style
Alvarez-Mon, M. A., Ortega, M. A., GarcÃa-Montero, C., Fraile-Martinez, O., Monserrat, J., Lahera, G., Mora, F., Rodriguez-Quiroga, A., Fernandez-Rojo, S., Quintero, J., & Alvarez-Mon, M.
(2021). Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals, 14(8), 821.
https://doi.org/10.3390/ph14080821
